Articles

Videos

Podcasts

Clinical

Medi-Dose, Inc/EPS, Inc Announces New Line of USP <800> Labels

Diane McCarthy, director of biologics pipeline development at US Pharmacopeia (USP), discusses USP’s development of mRNA quality guidelines to help companies and regulators bring innovative medicines to market faster.

USP Requests Feedback From Pharmacists to Advance mRNA Quality Guidelines

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how building resilience in the medicine supply chain will help bolster preparedness for what may arise during the COVID-19 pandemic and beyond.

Building Resilience in US Medicine Supply Chain Can Bolster Preparedness for What May Come During the Pandemic

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses contributing factors leading to health care professionals experience of an erosion of trust in the medicine supply chain.

Addressing the Erosion of Trust in US Medicine Supply Chain Among Health Care Professionals

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how drug shortages are related to medicine quality issues.

USP CEO: Why Medicine Quality May Have Been Impacted During the Pandemic

Ronald T. Piervincenzi, CEO of US Pharmacopeia (USP), discusses recent survey data demonstrating 90% of physicians had experienced an erosion of trust in the US supply chain’s ability to deliver safe, quality medicines.

USP Survey Shows 9 Out of 10 Physicians Feel Their Trust in Medicine Supply Chain Has Eroded

Emily Kaine, MD, senior VP global health and manufacturing services at US Pharmacopeia (USP), discusses the work USP is engaged in to strengthen the global supply chain of quality-assured medicines and build manufacturing capabilities for new and innovative medicines.

How USP Is Working to Strengthen Global Supply Chain of Quality-Assured Medicines, Build Manufacturing Capabilities

Amy Summers, consultant at Restore Health Consulting, discusses the proposed changed to the USP 795 and 797.

Pharmacy Focus Podcast: Pharmacy Tech Talk- Episode 4

Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, explains how pharmacists and USP came together in 2021 to work harder than ever before, as well as what can be done now to prepare for the next health crisis.

Expert: Pharmacists, USP Worked Together ‘A Hundred Times Faster Than Ever Before’ in 2021

Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, discusses what stands out as the biggest challenge from the past year and what role USP and pharmacists had in overcoming that challenge.

Expert: USP, Pharmacy Came Together in 2021 to Create Vaccine Toolkits ‘For Every Vaccine Created’

® 503B Compounding Pharmacy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to compounding pharmacies and drug safety.